Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment: Mifamurtide pharmacokinetics and pharmacodynamics in renal impairment
|
journal
|
May 2014 |
Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors
|
journal
|
February 2015 |
Biomolecular coronas provide the biological identity of nanosized materials
|
journal
|
December 2012 |
Mechanistic Modeling Identifies Drug-Uptake History as Predictor of Tumor Drug Resistance and Nano-Carrier-Mediated Response
|
journal
|
November 2013 |
Announcing the worldwide Protein Data Bank
|
journal
|
December 2003 |
A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature
|
journal
|
February 2013 |
Computational approaches and metrics required for formulating biologically realistic nanomaterial pharmacokinetic models
|
journal
|
January 2013 |
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
|
journal
|
December 2012 |
Competitive Binding of Proteins to Gold Nanoparticles Disclosed by Molecular Dynamics Simulations
|
journal
|
September 2015 |
Multiscale Kinetic Modeling of Liposomal Doxorubicin Delivery Quantifies the Role of Tumor and Drug-Specific Parameters in Local Delivery to Tumors
|
journal
|
November 2012 |
Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner
|
journal
|
April 2017 |
A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors
|
journal
|
December 2013 |
Tracking T-cells in vivo with a new nano-sized MRI contrast agent.
|
text
|
January 2012 |
Preclinical evaluation of genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer.
|
journal
|
May 2013 |
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
|
journal
|
March 2011 |
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors
|
journal
|
December 2013 |
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia
|
journal
|
November 2000 |
Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats
|
journal
|
January 2014 |
Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements
|
journal
|
August 2013 |
To scale or not to scale: the principles of dose extrapolation
|
journal
|
July 2009 |
Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability
|
journal
|
January 2010 |
Physical Principles of Nanoparticle Cellular Endocytosis
|
journal
|
August 2015 |
Margination of micro- and nano-particles in blood flow and its effect on drug delivery
|
journal
|
May 2014 |
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
|
journal
|
June 2009 |
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma
|
journal
|
May 2000 |
Physiologically Based Pharmacokinetic Modeling of Nanoparticles
|
journal
|
October 2010 |
A two-step model of TiO 2 nanoparticle toxicity in human liver tissue
|
journal
|
November 2017 |
Mifamurtide for the treatment of nonmetastatic osteosarcoma
|
journal
|
January 2011 |
Liposomal Formulations in Clinical Use: An Updated Review
|
journal
|
March 2017 |
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer
|
text
|
January 2013 |
Mathematical modeling in cancer drug discovery
|
journal
|
February 2014 |
A Theoretical Model for the Margination of Particles within Blood Vessels
|
journal
|
February 2005 |
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
|
journal
|
February 2020 |
Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
|
journal
|
June 2017 |
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
|
journal
|
April 2012 |
99m Tc-Labeled Multifunctional Low-Generation Dendrimer-Entrapped Gold Nanoparticles for Targeted SPECT/CT Dual-Mode Imaging of Tumors
|
journal
|
July 2016 |
Biodistribution and Pharmacokinetic Analysis of Long-Circulating Thiolated Gelatin Nanoparticles Following Systemic Administration in Breast Cancer-Bearing Mice
|
journal
|
February 2007 |
Understanding and modulating the competitive surface-adsorption of proteins through coarse-grained molecular dynamics simulations
|
journal
|
January 2013 |
Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics
|
dataset
|
January 2018 |
Liposomal nanomedicines
|
journal
|
December 2007 |
Kinetics of the formation of a protein corona around nanoparticles
|
journal
|
December 2016 |
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
|
journal
|
October 2006 |
Cancer nanomedicine: progress, challenges and opportunities
|
journal
|
November 2016 |
The Transport of Nanoparticles in Blood Vessels: The Effect of Vessel Permeability and Blood Rheology
|
journal
|
January 2008 |
Determining the Pharmacokinetics and Long-Term Biodistribution of SiO 2 Nanoparticles In Vivo Using Accelerator Mass Spectrometry
|
journal
|
October 2012 |
Diffusion Anisotropy in Collagen Gels and Tumors: The Effect of Fiber Network Orientation
|
journal
|
November 2010 |
The influence of size, shape and vessel geometry on nanoparticle distribution
|
journal
|
July 2012 |
The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems
|
journal
|
March 2013 |
Mechanism of hard-nanomaterial clearance by the liver
|
journal
|
August 2016 |
Analytical model of magnetic nanoparticle transport and capture in the microvasculature
|
journal
|
June 2006 |
A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4: PBPK for pregnancy with time-varying physiological parameters
|
journal
|
October 2012 |
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer
|
journal
|
July 2013 |
In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics
|
journal
|
October 2012 |
Pharmacokinetics of the Urokinase Receptor-Derived Peptide UPARANT After Single and Multiple Doses Administration in Rats
|
journal
|
October 2020 |
Odyssey of a cancer nanoparticle: From injection site to site of action
|
journal
|
December 2012 |
Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill
|
journal
|
June 2016 |
On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better
|
journal
|
June 2013 |
Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
|
journal
|
May 2014 |
Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach
|
journal
|
June 2015 |
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies
|
journal
|
June 2004 |
Effects of particle size and ligand density on the kinetics of receptor-mediated endocytosis of nanoparticles
|
journal
|
January 2010 |
Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles
|
journal
|
April 2016 |
Understanding the Kinetics of Protein–Nanoparticle Corona Formation
|
journal
|
November 2016 |
Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening
|
journal
|
November 2012 |
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release
|
journal
|
February 2016 |
The adhesive strength of non-spherical particles mediated by specific interactions
|
journal
|
October 2006 |
Tracking T-cells in vivo with a new nano-sized MRI contrast agent.
|
text
|
January 2012 |
Design of bio-mimetic particles with enhanced vascular interaction
|
journal
|
August 2009 |
Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics
|
journal
|
October 2018 |
Understanding Drug Resistance in Breast Cancer with Mathematical Oncology
|
journal
|
April 2014 |
Dynamics of Nanoparticle-Protein Corona Complex Formation: Analytical Results from Population Balance Equations
|
journal
|
May 2013 |
Multiscale modelling and nonlinear simulation of vascular tumour growth
|
journal
|
September 2008 |
Quantitative Whole Body Biodistribution of Fluorescent-Labeled Agents by Non-Invasive Tomographic Imaging
|
journal
|
June 2011 |
Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats
|
text
|
January 2016 |
[186Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model
|
journal
|
July 2009 |
Renal clearance of quantum dots
|
journal
|
September 2007 |
The Receptor-Mediated Endocytosis of Nonspherical Particles
|
journal
|
May 2008 |
ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance
|
journal
|
February 2012 |
Multiscale Cancer Modeling
|
journal
|
August 2011 |
Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging: Pharmacokinetic Profiling of Nanoparticles With MRI
|
journal
|
November 2008 |
Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data
|
journal
|
March 2017 |
Physiologically Based Pharmacokinetic Modeling: Principles and Applications
|
journal
|
October 1983 |
Influence of red blood cells on nanoparticle targeted delivery in microcirculation
|
journal
|
January 2012 |
In vivo SPECT/CT imaging and biodistribution using radioactive Cd 125 m Te/ZnS nanoparticles
|
journal
|
April 2007 |
Understanding the Connection between Nanoparticle Uptake and Cancer Treatment Efficacy using Mathematical Modeling
|
journal
|
May 2018 |
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
|
journal
|
November 2006 |
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
|
journal
|
January 2003 |
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
|
journal
|
July 2009 |
The Effective Dispersion of Nanovectors Within the Tumor Microvasculature
|
journal
|
March 2006 |
Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid
|
journal
|
June 2010 |
Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages
|
journal
|
January 2011 |
Evaluation of Drug-Loaded Gold Nanoparticle Cytotoxicity as a Function of Tumor Vasculature-Induced Tissue Heterogeneity
|
journal
|
October 2018 |
Delivering nanomedicine to solid tumors
|
journal
|
September 2010 |
Continuous and Discrete Mathematical Models of Tumor-induced Angiogenesis
|
journal
|
September 1998 |
Predictive Modeling of Drug Response in Non-Hodgkin’s Lymphoma
|
journal
|
June 2015 |
In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles
|
journal
|
January 2010 |
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
|
journal
|
October 2014 |
Evolution and clinical translation of drug delivery nanomaterials
|
journal
|
August 2017 |
Nanomedicines for Cancer Therapy: An Update of FDA Approved and Those under Various Stages of Development
|
journal
|
January 2014 |
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows
|
journal
|
November 2009 |
Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies
|
journal
|
August 2006 |
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
|
journal
|
August 2012 |
Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats
|
text
|
January 2016 |
Biodistribution and Pharmacokinetics of EGFR-Targeted Thiolated Gelatin Nanoparticles Following Systemic Administration in Pancreatic Tumor-Bearing Mice
|
journal
|
April 2013 |
Coarse-grained model of adsorption of blood plasma proteins onto nanoparticles
|
journal
|
December 2015 |
Probing In Vivo Trafficking of Polymer/DNA Micellar Nanoparticles Using SPECT/CT Imaging
|
journal
|
September 2011 |
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
|
journal
|
August 2013 |
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
|
journal
|
February 2016 |
Dynamic density functional theory of protein adsorption on polymer-coated nanoparticles
|
journal
|
January 2014 |
Combined mathematical modelling and experimentation to predict polymersome uptake by oral cancer cells
|
journal
|
February 2014 |
Antitumor Effect of Nanoparticle 131 I-Labeled Arginine-Glycine-Aspartate–Bovine Serum Albumin–Polycaprolactone in Lung Cancer
|
journal
|
May 2017 |
Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer
|
journal
|
April 2013 |
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
|
journal
|
July 2011 |
Pros and Cons of the Liposome Platform in Cancer Drug Targeting
|
journal
|
January 2006 |
Tracking T-cells in vivo with a new nano-sized MRI contrast agent
|
journal
|
November 2012 |
Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development
|
journal
|
January 2011 |
Coarse-grained models for proteins
|
journal
|
April 2005 |
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements
|
journal
|
June 2009 |
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution
|
journal
|
February 2012 |
Analysis of nanoparticle delivery to tumours
|
journal
|
April 2016 |
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
|
journal
|
December 2011 |
Nanomedicines for Cancer Therapy: An Update of FDA Approved and Those under Various Stages of Development
|
journal
|
January 2014 |
Protein adsorption on nanoparticles: model development using computer simulation
|
journal
|
August 2016 |
Nonlinear simulation of tumor growth
|
journal
|
March 2003 |
Simulating cancer growth with multiscale agent-based modeling
|
journal
|
February 2015 |
A closer look into the ubiquitin corona on gold nanoparticles by computational studies
|
journal
|
January 2015 |
Dual-radiolabeled nanoparticle SPECT probes for bioimaging
|
journal
|
January 2015 |
Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions
|
journal
|
January 2016 |
Machine learning provides predictive analysis into silver nanoparticle protein corona formation from physicochemical properties
|
journal
|
January 2018 |
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
|
journal
|
January 2001 |
Scale-Invariant Behavior and Vascular Network Formation in Normal and Tumor Tissue
|
journal
|
September 1995 |
Editorial Special Section on Multiscale Cancer Modeling
|
journal
|
March 2017 |
Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy
|
journal
|
March 2006 |
Transport properties of pancreatic cancer describe gemcitabine delivery and response
|
journal
|
March 2014 |
Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging
|
journal
|
September 2010 |
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
|
journal
|
April 2009 |
A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles
|
journal
|
September 2013 |
Coarse-grained model of adsorption of blood plasma proteins onto nanoparticles
|
text
|
January 2015 |